TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 1 filers reported holding TANGO THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,093,800 | +239.2% | 630,000 | 0.0% | 2.17% | +491.6% |
Q2 2023 | $2,091,600 | -15.9% | 630,000 | 0.0% | 0.37% | -28.6% |
Q1 2023 | $2,488,500 | -45.5% | 630,000 | 0.0% | 0.51% | -47.7% |
Q4 2022 | $4,567,500 | +100.2% | 630,000 | 0.0% | 0.98% | +84.8% |
Q3 2022 | $2,281,000 | -20.1% | 630,000 | 0.0% | 0.53% | -30.1% |
Q2 2022 | $2,854,000 | -40.2% | 630,000 | 0.0% | 0.76% | -36.7% |
Q1 2022 | $4,775,000 | -30.7% | 630,000 | 0.0% | 1.20% | -10.1% |
Q4 2021 | $6,892,000 | -23.9% | 630,000 | -10.0% | 1.34% | -5.8% |
Q3 2021 | $9,051,000 | – | 700,000 | – | 1.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 19,363,975 | $146,779,000 | 53.77% |
TCG Crossover Management, LLC | 1,254,500 | $9,509,000 | 3.82% |
Cormorant Asset Management, LP | 4,899,185 | $37,136,000 | 2.85% |
Boxer Capital, LLC | 6,871,642 | $52,087,000 | 2.68% |
Casdin Capital, LLC | 5,487,910 | $41,598,000 | 1.86% |
Bain Capital Life Sciences Investors, LLC | 1,921,790 | $14,567,000 | 1.42% |
Samsara BioCapital, LLC | 630,000 | $4,775,000 | 1.20% |
TANG CAPITAL MANAGEMENT LLC | 468,750 | $3,553,000 | 0.71% |
Southpoint Capital Advisors LP | 3,805,929 | $28,849,000 | 0.56% |
HARVARD MANAGEMENT CO INC | 708,385 | $5,370,000 | 0.54% |